NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704,314 | -0.8% | 6,915 | -1.7% | 0.16% | +6.1% |
| Q2 2023 | $709,959 | +7.8% | 7,036 | -1.7% | 0.15% | +9.6% |
| Q1 2023 | $658,839 | +80739.1% | 7,161 | -20.3% | 0.14% | -22.9% |
| Q4 2022 | $815 | -99.9% | 8,980 | +15.9% | 0.18% | +20.7% |
| Q3 2022 | $589,000 | -18.3% | 7,745 | -9.2% | 0.14% | -16.2% |
| Q2 2022 | $721,000 | -1.6% | 8,526 | +2.1% | 0.17% | -6.5% |
| Q1 2022 | $733,000 | +46.0% | 8,354 | +45.6% | 0.18% | +46.8% |
| Q4 2021 | $502,000 | -16.6% | 5,737 | -22.1% | 0.13% | -25.0% |
| Q3 2021 | $602,000 | +96.7% | 7,361 | +119.7% | 0.17% | +100.0% |
| Q2 2021 | $306,000 | +39.7% | 3,351 | +31.2% | 0.08% | -11.6% |
| Q3 2017 | $219,000 | +9.0% | 2,554 | +6.2% | 0.10% | +4.4% |
| Q2 2017 | $201,000 | -16.2% | 2,406 | -7.7% | 0.09% | -36.4% |
| Q3 2015 | $240,000 | – | 2,608 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |